企业主流与新流创新演进机理研究

激烈的市场竞争使人们意识到，企业既需要维持创新发展优势而抢占主流市场，又需要创造新的企业发展优势而赢取未来主流市场。着眼于这一关键任务，实现主流与新流创新演进成为企业持续发展的重点。因此，基于生物进化理论、企业进化理论和企业DNA理论，提出主流与新流创新演进经过了生成、变异、选择、协同阶段。深入研究主流与新流创新的生成、变异、选择、协同机理，并与企业创新发展实践相结合，为企业未来主流创新提供具体路径指导。     

数量驱动或创新驱动：异质型人力资本对经济增长的机制演进

基于1987-2017年中国省际面板数据，运用SYS-GMM模型研究异质型人力资本对经济增长的影响。在区分高级与基本人力资本基础上，基于招生率和收入维度，从全局和阶段差异视角剖析异质型人力资本对经济提速的机制演进。研究发现：全局而言，两种测度下基础和高级人力资本各自以数量及创新方式驱动经济增长，并呈现以数量驱动为主，数量、创新双驱动的增长模式；从演进视角看，两种测度均表明，高级人力资本创新驱动是新常态阶段经济增长的核心动力，但相比旧常态阶段，基础人力资本数量驱动日趋弱化并呈异质性；进一步研究表明，产业结构、城镇化及开放程度均对创新驱动有不同程度激励效应，而城镇化是挤出数量驱动的主要推手。     

NVC龙企功能升级模式演进及机理纵向案例研究——技术自主性视角

国内龙头企业核心技术自主可控成为制约NVC（国内价值链）功能升级的关键问题。通过文献归纳，以能力自主与产权自主解构技术自主性内涵，并根据产品平台与技术轨道双维度划分NVC龙企功能升级模式。基于“能力—战略—行为—绩效（RSCP）”分析框架，选取华为海思公司作为纵向案例研究对象，探索技术自主性视角下NVC龙企功能升级模式及演进机理。结果发现，模块创新与知识产权创造能力通过产品渐进升级模式提升供应链；架构创新与知识产权布局能力可以调整技术轨道，通过产品突破升级模式I打通创新链；架构创新、模块创新和知识产权运营能力可以变革技术轨道，通过产品突破升级模式II主导价值链。     

创新网络领域知识主题研究述评

在知识经济时代，创新网络在企业创新中扮演着重要角色，而研究网络中知识要素的产生、传播、吸收等问题对了解企业网络化创新具有重要意义。基于国内外核心文献数据库，收集创新网络领域知识要素相关文献，并结合文献计量分析方法，对该领域近30年有关知识主题研究的演化规律、整体趋势等进行梳理。结果表明，国内外研究年度发文量均呈现3个阶段变化趋势，且分别拥有各自重要载文期刊，国内研究已形成核心团队，而国外并未形成；国内外研究既有相同之处，也存在差异性，且均形成较为清晰的研究框架；在演化规律上，国内横向拓展和纵向深化研究特征显著，而国外更加注重纵向深入探索分析，研究内容也更加分散；在未来前沿热点分析上，中外学者关注内容既有相同点，也有不同点，知识协同、知识惯例、企业数字化转型对知识影响的研究是未来关注重点。     

科技型小微企业创新生态系统网络治理研究

建立一个完整、高效的创新生态系统是破解科技型小微企业创新困境、提高创新效率，以及助力新旧动能转换的有效途径。基于生态系统理论和演化动力学模型，构建科技型小微企业创新生态系统网络框架和网络联结模式，利用竞争、互利共生和捕食关系演化模型，分析演化模型的均衡点及其稳定条件。结果发现，创新生态位重叠程度决定了竞争激烈程度，系统演化均衡条件是主体间分工程度高，且嵌入适度。最后，从价值主体和机构主体两个方面〖JP〗提出推进科技型小微企业创新生态系统不断进化的治理策略。     

An evolutionary complex systems perspective on urban health

Deliberations about how to govern complex problems of urban health and wellbeing sustainably have often been implicitly biased by ideas such as being ‘human-scale’ or ‘people-centered.’ With increasing urban populations and increasing urban system interconnectivity, many cities have transformed into city regions or clusters, and the external effects of urban growth are carried mainly by the marginalized and the environment putting urban health increasingly at risk. Here we address the question of why human societies have not been better at collectively adapting to the challenges of urbanization and global environmental change? We build a theoretical framework of multi-level selection, complex systems evolution, and governance, following which we then present ‘human-scale’ and ‘people-centered’ ideas of urban development as expressions of two types of socio-political organization with different degrees of self-organization. We found several reasons for which the maladies of current urban development emerged and the seeming inability to resolve them. First, urban systems became increasingly interconnected and evolved into ultrasocial superorganisms, displaying preference to sustain themselves as a whole rather than their subordinates. Second, the difference in scaling effects between the biological and the social network contributed to the mismatch between rapid urban growth and slow adaptation. Furthermore, institutions of decreased variety reinforce themselves and become dominant, creating a positive feedback mechanism and promoting invasive and exploitative exponential growth, but they also reduce the creativity and resilience of urban systems. We also found that both the “human-scale” and the “people-centered” approaches acknowledge the exponential growth and decreasing variety in urban systems, and advocate for correcting the mismatches. To incorporate people's needs and values for long-term, truly sustainable urban health governance, we recommend combining the self-organizing, evolutionary feature of “human-scale” and the coordinative, political feature of “people-centeredness.”     

基于关键节点与关键路径的专利集群网络演进研究

专利作为技术和知识的重要载体，是研究技术演进和产业发展的重要信息源。目前缺乏针对专利集群网络中关键节点与关键路径中节点的比较分析和技术知识挖掘。构建基于关键节点和关键路径的专利集群网络演进模型，从两个层面综合分析技术演进特征。检索德温特数据库(Derwent Innovation Index)得到碳化硅肖特基势垒二极管（SiC-SBD）相关专利作为实证数据，时间跨度为1986-2017年。结果表明，SiC-SBD专利集群网络经历了萌芽期、成长期、成熟期和衰退期，其中，萌芽期专利主要涉及基础技术，成长期为器件结构，以完善器件结构、改进二极管性能为主要研究方向。近年来SiC-SBD专利年增长率下降，技术发展速度放缓，专利价值更多体现在其商业价值上。SiC-SBD专利集群网络关键节点与关键路径中节点重合度较高，核心专利识别可通过多视角分析得到。通过关键节点与关键路径分析专利集群网络演进过程，有助于更全面呈现技术演进过程，为决策者识别核心专利、预测技术发展提供参考。     

国家科技创新能力时空差异性评价

科技创新规模扩张和科技创新效率提升是增强国家科技创新能力的两条关键途径。基于现有研究鲜有结合科技创新规模和科技创新效率开展国家科技创新能力评价的现状，采用因子分析法，系统筛选国家科技创新规模影响因素，并结合科技创新效率影响因素，完善国家科技创新能力评价指标体系，通过构建DEA Malmquist指数模型，评价不同时期国家科技创新效率变化指数，以及中国与全球10个国家科技创新能力的时空差异性。研究表明，R&D投入强度、R&D研究人员、专利申请量、科技期刊文章数、高科技产品出口额占制成品出口总额的百分比、科技创新效率是影响国家科技创新能力的关键指标；1991-2014年中国科技创新能力水平呈指数增长态势，有力提升了国家科技实力；全球10个国家科技创新能力水平除日本出现一定波动外，其余九国整体呈小幅递增态势。     

Identifying the internal structure evolution of urban built-up land sprawl (UBLS) from a composite structure perspective: A case study of the Beijing metropolitan area,China

Differences in the internal composite structure during urban built-up land sprawl (UBLS) will generate different effects, and thus, a city’s spatial structure has important bearings on urban sustainability. This study investigates the spatial and temporal characteristics of the internal structure and allocation relationship of UBLS using multivariate spatial correlation and the Weaver-Tomas composite coefficient based on site data of granted built-up land parcels. Moreover, the composite structure evolution process of UBLS and its driving mechanism are examined in this study. The results reveal that the amount structure of the three types of UBLS (i.e. industrial land sprawl, residential land sprawl and commercial land sprawl) tended to be balanced during the study period. Following the transformation and upgrade of the urban industry structure, the overall composite structure of UBLS ranged from single residential land-use structure (Res.) to industrial-residential land-use structure (Ind.-Res.) In the early period of land marketization, the marketization land granting mechanism caused low spatial correlation between the various types of UBLS and a single composite structure, i.e. Res., single commercial land-use structure (Com.), and residential-commercial land-use structure (Res.-Com.). Subsequently, a dual-driving force including the market economy and government interventions caused a relatively high degree of spatial correlation and a multiple composite structure, i.e. Ind.-Res. and industrial-residential-commercial land-use structure (Ind.-Res.-Com.). However, the evolution characteristics of the composite structure in various regions illustrate some problems, such as the spatial isomorphism phenomenon of the composite structure and the dislocation of urban built-up land allocation. The urban internal built-up land spatial layout pattern is the embodiment of two dominant driving forces, the market and the government, interacting with each other according to natural and socioeconomic conditions. Therefore, we suggest that it is necessary to reform the future urban built-up land granting mechanism based on market guidance, and the composite structure of UBLS should be adjusted according to the regional function. The government should reinforce the macro-control of land-use planning for the dispersed granted land parcels so as to optimize the urban land-use structure.     

How technological innovation affects the structure of an industry: entrepreneurship evolution in the biotechnology and pharmaceutical industry since 1980

Challenges faced by the biotechnology and pharmaceutical industry, including reduced R&D productivity and the expiration of drugs that are high in demand, are recently being addressed through technological innovation. Such innovations are highly likely to change the structure and functioning of the industry. Since 2000, biotechnology and pharmaceutical companies have actively made strategic alliance, and technological innovations have changed the source of innovation from R&D to entrepreneurship within the industry. In this study, we identify the evolution of entrepreneurship and discuss the changes caused by technological advancements since 1980 by analysing patterns of exporting and acquiring technology data from Medtrack. Over difference period, biopharmaceutical firms have gained new knowledge and improved technology, and have implemented this newly acquired knowledge and innovation to introduce drugs to the market.